Skip to main content
Fig. 1 | Trials

Fig. 1

From: Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial

Fig. 1

Multimodal imaging in chronic central serous chorioretinopathy. Examples of fluorescein angiography (FA), indocyanine green (ICG) angiography and spectral-domain optical coherence tomography (SD-OCT) in chronic central serous chorioretinopathy (cCSC). (a-c) Right eye of a patient with cCSC with more widespread leakage on FA (a) corresponding with hyperfluorescent areas on ICG angiography (b) and SRF on SD-OCT (c)

Back to article page